| Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
|---|---|---|---|---|---|
| Log P | 2.24 | - | 2.24 | - | MSDS |
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
|---|---|---|---|---|---|---|
| T Max | 4.0 | h | 4 | h | DRUGBANK | |
| Clearance | 10.3 | L/h | 10.3 | L/h | DRUGBANK | |
| Volume of Distribution | 1180.0 | L | 1180.0 | L | Apparent volume of distribution; | DRUGBANK |
| Half-life | 79.1 | h | 79.1 | h | elimination half-life; | DRUGBANK |
| Toxicity LD50 | 2000.0 | mg/kg | >2000 | mg/kg | PO, oral; Rattus, Rat; | DRUGBANK |
| Eliminate Route | 14.7 | % | 14.7 | % | Urinary excretion; Single dose; | DRUGBANK | Eliminate Route | 80.1 | % | 80.1 | % | Faeces excretion; Single dose; | DRUGBANK |
| Protein Binding | 93.4 | % | 92.9-93.9 | % | DRUGBANK |
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
|---|---|---|---|---|---|---|---|---|
| Max dose for children | 80.0 | mg | 80 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
| Max dose for children | 40.0 | mg | 40 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
| Max dose for adolescents | 80.0 | mg | 80 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
| Max dose for adolescents | 40.0 | mg | 40 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
| Max dose for adults | 80.0 | mg | 80 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
| Max dose for adults | 40.0 | mg | 40 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
| Max dose for geriatric | 80.0 | mg | 80 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |
| Max dose for geriatric | 40.0 | mg | 40 | mg | PO, oral | Xofluza | baloxavir marboxil | PDR |